Annual Shareholders Equity
$3.99 M
-$1.17 M-22.66%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual stockholders equity is $3.99 million, with the most recent change of -$1.17 million (-22.66%) on December 31, 2023.
- During the last 3 years, LIXT annual shareholders equity has fallen by -$1.02 million (-20.30%).
- LIXT annual shareholders equity is now -22.66% below its all-time high of $5.17 million, reached on December 31, 2022.
Performance
LIXT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.37 M
-$879.20 K-39.14%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly stockholders equity is $1.37 million, with the most recent change of -$879.20 thousand (-39.14%) on September 30, 2024.
- Over the past year, LIXT quarterly shareholders equity has stayed the same.
- LIXT quarterly shareholders equity is now -82.13% below its all-time high of $7.65 million, reached on March 31, 2021.
Performance
LIXT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LIXT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.7% | 0.0% |
| 3 y3 years | -20.3% | -49.2% |
| 5 y5 years | -3.2% | -49.2% |
LIXT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.7% | at low | -81.8% | at low |
| 5 y | 5-year | -22.7% | +64.1% | -82.1% | +19.8% |
| alltime | all time | -22.7% | +1334.9% | -82.1% | +522.5% |
Lixte Biotechnology Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.37 M(-39.1%) |
| Jun 2024 | - | $2.25 M(-28.2%) |
| Mar 2024 | - | $3.13 M(-21.7%) |
| Dec 2023 | $3.99 M(-22.7%) | $3.99 M(-18.9%) |
| Sep 2023 | - | $4.92 M(+82.8%) |
| Jun 2023 | - | $2.69 M(-34.0%) |
| Mar 2023 | - | $4.08 M(-21.0%) |
| Dec 2022 | $5.17 M(+7.8%) | $5.17 M(-19.4%) |
| Sep 2022 | - | $6.41 M(-14.4%) |
| Jun 2022 | - | $7.49 M(+115.7%) |
| Mar 2022 | - | $3.47 M(-27.5%) |
| Dec 2021 | $4.79 M(-4.4%) | $4.79 M(-21.1%) |
| Sep 2021 | - | $6.07 M(-11.5%) |
| Jun 2021 | - | $6.87 M(-10.2%) |
| Mar 2021 | - | $7.65 M(+52.6%) |
| Dec 2020 | $5.01 M(+105.9%) | $5.01 M(+339.3%) |
| Sep 2020 | - | $1.14 M(-32.0%) |
| Jun 2020 | - | $1.68 M(-18.2%) |
| Mar 2020 | - | $2.05 M(-15.7%) |
| Dec 2019 | $2.43 M(-41.0%) | $2.43 M(-11.7%) |
| Sep 2019 | - | $2.76 M(-18.8%) |
| Jun 2019 | - | $3.40 M(-8.5%) |
| Mar 2019 | - | $3.71 M(-10.1%) |
| Dec 2018 | $4.13 M(+314.7%) | $4.13 M(<-9900.0%) |
| Sep 2018 | - | -$14.10 K(-105.8%) |
| Jun 2018 | - | $244.50 K(-60.3%) |
| Mar 2018 | - | $615.90 K(-38.1%) |
| Dec 2017 | $995.00 K(+363.2%) | $995.00 K(-28.7%) |
| Sep 2017 | - | $1.39 M(-23.5%) |
| Jun 2017 | - | $1.82 M(+173.7%) |
| Mar 2017 | - | $666.10 K(+210.1%) |
| Dec 2016 | $214.80 K(-31.2%) | $214.80 K(-70.9%) |
| Sep 2016 | - | $738.00 K(-40.4%) |
| Jun 2016 | - | $1.24 M(+20.1%) |
| Mar 2016 | - | $1.03 M(+230.5%) |
| Dec 2015 | $312.30 K | $312.30 K(-61.2%) |
| Sep 2015 | - | $804.90 K(-39.3%) |
| Jun 2015 | - | $1.33 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $1.43 M(+437.0%) |
| Dec 2014 | $265.90 K(+12.5%) | $265.90 K(-55.2%) |
| Sep 2014 | - | $593.90 K(-39.1%) |
| Jun 2014 | - | $975.00 K(-1112.5%) |
| Mar 2014 | - | -$96.30 K(-140.8%) |
| Dec 2013 | $236.30 K(-84.2%) | $236.30 K(-59.3%) |
| Sep 2013 | - | $580.30 K(-34.0%) |
| Jun 2013 | - | $878.70 K(-27.4%) |
| Mar 2013 | - | $1.21 M(-18.8%) |
| Dec 2012 | $1.49 M(+1788.5%) | $1.49 M(-13.0%) |
| Sep 2012 | - | $1.72 M(-9.9%) |
| Jun 2012 | - | $1.90 M(-816.6%) |
| Mar 2012 | - | -$265.60 K(-436.2%) |
| Dec 2011 | $79.00 K(-95.5%) | $79.00 K(-87.6%) |
| Sep 2011 | - | $638.10 K(-41.1%) |
| Jun 2011 | - | $1.08 M(-21.8%) |
| Mar 2011 | - | $1.39 M(-20.2%) |
| Dec 2010 | $1.74 M(+33.4%) | $1.74 M(+0.9%) |
| Sep 2010 | - | $1.72 M(-6.5%) |
| Jun 2010 | - | $1.84 M(-13.7%) |
| Mar 2010 | - | $2.13 M(+63.8%) |
| Dec 2009 | $1.30 M(-502.2%) | $1.30 M(-567.0%) |
| Sep 2009 | - | -$278.60 K(+266.6%) |
| Jun 2009 | - | -$76.00 K(-47.0%) |
| Mar 2009 | - | -$143.50 K(-55.6%) |
| Dec 2008 | -$323.50 K(-185.8%) | -$323.50 K(+92.3%) |
| Sep 2008 | - | -$168.20 K(-1562.6%) |
| Jun 2008 | - | $11.50 K(-92.2%) |
| Mar 2008 | - | $147.70 K(-60.8%) |
| Dec 2007 | $376.90 K(-39.8%) | $376.90 K(+1164.8%) |
| Sep 2007 | - | $29.80 K(-82.7%) |
| Jun 2007 | - | $172.40 K(-49.2%) |
| Mar 2007 | - | $339.40 K(-45.8%) |
| Dec 2006 | $626.60 K(-4391.8%) | $626.60 K(-15.6%) |
| Sep 2006 | - | $742.30 K(+79.2%) |
| Jun 2006 | - | $414.30 K(-4284.8%) |
| Mar 2006 | - | -$9900.00 |
| Dec 2005 | -$14.60 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual shareholders equity year-on-year change?
- What is Lixte Biotechnology Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly shareholders equity year-on-year change?
What is Lixte Biotechnology Holdings annual stockholders equity?
The current annual shareholders equity of LIXT is $3.99 M
What is the all time high annual shareholders equity for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual stockholders equity is $5.17 M
What is Lixte Biotechnology Holdings annual shareholders equity year-on-year change?
Over the past year, LIXT annual stockholders equity has changed by -$1.17 M (-22.66%)
What is Lixte Biotechnology Holdings quarterly stockholders equity?
The current quarterly shareholders equity of LIXT is $1.37 M
What is the all time high quarterly shareholders equity for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly stockholders equity is $7.65 M
What is Lixte Biotechnology Holdings quarterly shareholders equity year-on-year change?
Over the past year, LIXT quarterly stockholders equity has changed by $0.00 (0.00%)